Replies to post #58166 on Amarin Corp Plc (AMRN)

[zumantu]

Kiwi, ? Are you really serious with that question? the ONLY reason to settle would be to get more than what they already have (the 1A)

take your pick;

Anchor on label (improves ins coverage)
Expanded indication (guarantees ins coverage)

in meantime Amarin is going balls to walls with multiple JELIS studies 0- sub analysis etc etc

They are going great guns with the Judge and a powerful legal representation solidly behind them

FDA does not give a crap about Vascepa - its a side show - they are trembling about 1A decision and wave of suits coming